Re: German drug maker Morphosys to buy Constellation Pharma in $1.7 billion deal
|
8
|
Zenith Epigenetics
|
Jun 05, 2021 07:23PM
|
Re: Differences of Opinion
|
8
|
Zenith Epigenetics
|
May 24, 2016 04:25PM
|
Re: New Apabetalone Fabry Disease Publication
|
8
|
Resverlogix Corp.
|
Apr 29, 2022 12:29PM
|
Re: Article
|
8
|
Resverlogix Corp.
|
May 30, 2022 11:40AM
|
Re: Surf's up
|
8
|
Resverlogix Corp.
|
Feb 06, 2020 12:43PM
|
Re: Merck and Pfizer competition for a COVID 19 pill (Stat News)
|
8
|
Resverlogix Corp.
|
Apr 09, 2021 02:07PM
|
Re: Resverlogix In Active Discussions With The Kingdom of Morocco’s Ministry of Health For The Launch Of COVID-19 Clinical Studies With First-In-Class Dru
|
8
|
Resverlogix Corp.
|
Nov 01, 2021 12:07PM
|
Diabetic kidney disease
|
7
|
Resverlogix Corp.
|
Nov 02, 2016 01:11PM
|
Thank you BKC
|
7
|
Resverlogix Corp.
|
Feb 27, 2017 12:48PM
|
Re: Any thoughts on the loan?
|
7
|
Resverlogix Corp.
|
Jul 13, 2017 08:01PM
|
Re: Resverlogix Reschedules Update Webcast and Conference Call: Now February 4th 10AM MT
|
7
|
Resverlogix Corp.
|
Jan 27, 2021 08:52PM
|
Re: Sparks Therapeutics Gene Therapy Deal
|
7
|
Resverlogix Corp.
|
Feb 24, 2019 05:27PM
|
Re: Zenith and Newsoara Biopharma Announce Expanded Licensing and Investment.
|
7
|
Zenith Epigenetics
|
Nov 17, 2021 12:28PM
|
Re: Eastern private placement
|
7
|
Zenith Epigenetics
|
May 19, 2016 01:53PM
|
Re: possible catalyst(s)??
|
7
|
Zenith Epigenetics
|
Dec 21, 2021 06:12PM
|
Re: Can big pharma afford Apabetalone?
|
7
|
Resverlogix Corp.
|
Jun 17, 2018 09:28PM
|
Warrant Incentive Plan
|
7
|
Resverlogix Corp.
|
Nov 25, 2019 08:25PM
|
Re: "Actively Recruiting" ?
|
7
|
Resverlogix Corp.
|
Nov 04, 2021 03:05PM
|
Re: Resverlogix Announces US$30 Million Loan Commitment Letter .
|
7
|
Resverlogix Corp.
|
Apr 11, 2018 08:54AM
|
Re: Posted on other board by jkj from Google alert / Old or new news?
|
7
|
Resverlogix Corp.
|
Apr 18, 2021 06:59PM
|